CONGRESS ENACTED LEGISLATION LAST MONTH that suspends implementation of the next round of price cuts to the Medicare Part B Clinical Laboratory Fee Schedule (CLFS) that was scheduled to take effect on Jan. 1. This is a welcome development for the medical laboratory industry. A two-paragraph inclusion in a 4,000- page, year-end government spending bill […]
To access this post, you must purchase The Dark Report.